Northwire Canada EditionFriday, July 31, 2026
Northwire
FCI 0.415 −3.5% SGQ 0.350 +0.0% SASK 0.980 −3.9% WGX 4.58 −1.8% GMX 1.86 +1.6% DSV 8.83 −3.2% MQM 0.170 +0.0% MNO 1.51 −3.2% VIZ 0.190 +0.0% HBM 32.10 +0.8% CNC 1.53 −3.2% ALGR 0.490 −7.5% MSG 0.200 −2.4% ECU 1.73 +2.4% NAM 0.250 −2.0% FDY 5.60 +0.7% FCI 0.415 −3.5% SGQ 0.350 +0.0% SASK 0.980 −3.9% WGX 4.58 −1.8% GMX 1.86 +1.6% DSV 8.83 −3.2% MQM 0.170 +0.0% MNO 1.51 −3.2% VIZ 0.190 +0.0% HBM 32.10 +0.8% CNC 1.53 −3.2% ALGR 0.490 −7.5% MSG 0.200 −2.4% ECU 1.73 +2.4% NAM 0.250 −2.0% FDY 5.60 +0.7%
Financings

Northfield Announces Upsized Brokered Financing of up to $15 Million

NFDA · Price

Executive Summary

  • Northfield Capital Corporation upsized its previously announced brokered financing to a maximum of $15 million in gross proceeds, pricing each unit at $5.50 (one Class A restricted voting share plus one warrant).
  • The company also proposes a private placement of up to 1,192 additional Class B multiple‑voting shares to President/CEO Robert Cudney at $6.40 per share, bringing the total potential Class B issuance to 3,580 shares (≈ $7,629 gross).
  • Net proceeds from both the unit offering and the Class B share issue will be used for working capital and general corporate purposes; closing is expected around December 9, 2025, subject to TSX‑V approval.

Key Details

  • Upsized Unit Offering
  • Maximum aggregate gross proceeds: $15,000,000.
  • Issue price per unit: $5.50.
  • Each unit consists of one Class A restricted voting share + one warrant (exercise price $7.50, three‑year term).
  • Lead agent/sole bookrunner: Integrity Capital Group Inc. (syndicate of agents).
  • Closing expected on or about December 9, 2025, subject to TSX Venture Exchange approval.

  • Use of Proceeds – Unit Offering

  • Fund operational expenditures and general corporate purposes.

  • Class B Share Private Placement

  • Up to 1,192 additional Class B shares offered to Robert Cudney at $6.40 per share, gross proceeds up to $7,629.
  • Combined with prior proposed issuance, total potential Class B shares to Cudney: 3,580 shares.
  • Purpose: maintain Cudney’s pro‑rata voting interest after the unit offering.
  • Subject to Exchange approval; statutory hold period of four months plus one day from closing.

  • Use of Proceeds – Class B Issue

  • Working capital and general corporate purposes.

  • Related Party & Regulatory Considerations

  • Both transactions qualify as “related party transactions” under MI 61‑101 but are exempt from formal valuation/minority approval because fair market value is below 25 % of market capitalization.
  • All securities to be issued pursuant to the relevant TSX Venture Exchange policies and exemptions (NI 45‑106, Blanket Order 45‑935).

  • Advisors

  • Legal counsel for Northfield: Cassels Brock & Blackwell LLP.
  • Legal counsel for agents: Bennett Jones LLP.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from None